This episode of Science Quickly is brought to you by Regeneron.
Regeneron is a leading biotechnology company that invents, develops,
and delivers life-transforming medicines for people with serious diseases.
Founded and led by physician scientists, Regeneron pushes the boundaries
of scientific discovery from proprietary antibody technologies to pioneering genetic medicine platforms.
And through their extensive STEM programming and partnerships, including the Regeneron Science Talent Search
and the Regeneron International Science and Engineering Fair,
they're empowering future scientific innovators to pursue bold ideas and advance world-changing solutions.
Learn more at Regeneron.com.
For Scientific American Science Quickly, I'm Rachel Feldman.
Today we're back with another one of Siam's 2026 young American scientists.
This group of groundbreaking researchers represent the future of science, technology and medicine.
One of those honorees is Calle Machado-Costa,
an assistant professor at the Department of Psychology at the University of Alabama at Birmingham.
He studies how learning works on a neurological level.
Thanks so much for coming on to chat with us today.
This is my great pleasure.
Before we get into the subject of your research specifically,
I have to ask if you would tell me why you describe yourself as slightly cursed.
Over the course of my career, there have been only very few instances where I have made a prediction, right?